carmustine has been researched along with didimethylsulfoxide dichloroplatinum(ii) in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheson, BD; Ungerleider, RS | 1 |
| Bubley, G; Coleman, CN; Eder, JP; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA | 1 |
| Biron, P; Bouffet, E; Brunat-Mentigny, M; Chauvin, F; Ladenstein, R; Lasset, C; Philip, I; Philip, T | 1 |
| Epelbaum, R; Frei, E; Herman, TS; Holden, SA; Liu, SD; Teicher, BA | 1 |
| Cathcart, KN; Eder, JP; Frei, E; Holden, SA; Schnipper, LE; Teicher, BA | 1 |
| Bernal, SD; Cathcart, KN; Holden, SA; Teicher, BA | 1 |
1 trial(s) available for carmustine and didimethylsulfoxide dichloroplatinum(ii)
| Article | Year |
|---|---|
A single center experience with bone marrow transplantation for high risk neuroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; France; Humans; Infant; Male; Neuroblastoma; Organoplatinum Compounds; Remission Induction; Reoperation; Survival Rate; Teniposide; Vincristine | 1991 |
5 other study(ies) available for carmustine and didimethylsulfoxide dichloroplatinum(ii)
| Article | Year |
|---|---|
Clinical trials referral resource. High priority trials--III. Breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Intraductal, Noninfiltrating; Carmustine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Mastectomy, Segmental; Organoplatinum Compounds; Tamoxifen | 1992 |
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbon Dioxide; Carboplatin; Carmustine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Etanidazole; Fibrosarcoma; Flow Cytometry; Fluorocarbons; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Melphalan; Mice; Nitroimidazoles; Organoplatinum Compounds; Oxygen; Radiation-Sensitizing Agents; Thiotepa | 1991 |
Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carboplatin; Carmustine; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Fibrosarcoma; Humans; Indazoles; Mammary Neoplasms, Animal; Mice; Organoplatinum Compounds; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1991 |
Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Survival; Cyclophosphamide; Fibrosarcoma; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Novobiocin; Organoplatinum Compounds | 1989 |
Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbon Dioxide; Carmustine; Cell Division; Cell Survival; Drug Combinations; Etoposide; Fluorocarbons; Hydroxyethyl Starch Derivatives; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Organoplatinum Compounds; Oxygen | 1988 |